Company Profile
Ceribell, Inc
Company Overview
Ceribell, Inc. is a medical device company based in California with a primary mission of improving neurological care for emergency and ICU patients. Ceribell is focused on making EEG widely accessible, more efficient, and more cost-effective to improve the diagnosis and treatment of patients at risk for seizure. The system can be set up by any healthcare provider within minutes and offers 24/7 continuous bedside EEG monitoring and alert. Real-time monitoring enables rapid and precise treatment for patients with seizures, leading to better clinical outcomes and significant savings. To learn more, visit www.ceribell.com.
Company History
Ceribell is a rapidly growing commercial stage digital healthcare company headquartered in Sunnyvale, CA.
Founded in 2014 by our CEO, Jane Chao and professors from Stanford University.
A novel electroencephalogram (EEG) platform technology and AI machine learning algorithm.
Adopted by 250+ hospitals, Ceribell has the only AI algorithm for seizures (status epilepticus) cleared by the FDA, greater than 100% revenue growth in 2021 and 2020.
Notable Accomplishments / Recognition
Only FDA approved device that provides seizure alerts at the bedside. Designed to improve the accessibility, speed and efficiency of diagnosing neurological patients, initially targeting seizures, a $2.7bn US market.
Benefits
Competitive compensation and stock
Exciting career growth opportunities
Comprehensive benefits (medical PPO, PMO, dental, vision, flex spending, life insurance & long-term disability, value added services, 401(k), etc.)
Flexible paid time off for exempt employees, plus 11 paid company holidays
Parental leave policies
Additional perks (phone, internet reimbursement, etc)